Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
5.62
-0.33 (-5.55%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Basel Medical Group Balance Sheet
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1.34 | 3.04 | 1.95 | 1.22 | 1.56 |
Cash & Short-Term Investments | 1.34 | 3.04 | 1.95 | 1.22 | 1.56 |
Cash Growth | -55.88% | 56.04% | 60.26% | -22.14% | - |
Accounts Receivable | 10.75 | 9.49 | 2.01 | 1.58 | 2.28 |
Other Receivables | 1.72 | - | 10.56 | 11.88 | 11.75 |
Total Trade Receivables | 12.47 | 9.49 | 12.56 | 13.46 | 14.03 |
Inventory | 0.33 | 0.49 | 0.07 | 0.09 | 0.07 |
Other Current Assets | 0.03 | 0.27 | 1.59 | - | - |
Total Current Assets | 14.18 | 13.29 | 16.17 | 14.77 | 15.67 |
Net Property, Plant & Equipment | 5.9 | 5.34 | 0.06 | 0.58 | 1.18 |
Long-Term Investments | 0 | - | - | - | - |
Other Long-Term Assets | 0.05 | 0.05 | 0.08 | 0.03 | 0 |
Total Assets | 20.12 | 18.68 | 16.31 | 15.38 | 16.85 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 3.67 | 6.57 | 2.58 | 2.19 | 2.41 |
Accrued Expenses | - | - | 0.44 | 0.48 | 0.39 |
Current Portion of Long-Term Debt | 2.94 | 2.12 | 2.71 | 3.79 | 4.2 |
Other Current Liabilities | 0.9 | 1.47 | 1.44 | 0.02 | 0.19 |
Total Current Liabilities | 7.52 | 10.16 | 7.16 | 6.47 | 7.19 |
Long-Term Debt | 6.04 | 2.96 | 1.58 | 3.42 | 5.95 |
Other Long-Term Liabilities | 0.04 | 0.12 | - | - | - |
Total Long-Term Liabilities | 6.08 | 3.08 | 1.58 | 3.42 | 5.95 |
Total Liabilities | 13.6 | 13.24 | 8.75 | 9.89 | 13.14 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 34.21 | 34.21 | 24.46 | 0 | 0 |
Additional Paid-in Capital | -24.21 | -24.46 | -24.46 | - | - |
Accumulated Other Comprehensive Income | -0.04 | -0.46 | - | - | - |
Retained Earnings | -3.69 | -3.85 | 7.56 | 5.49 | 3.71 |
Total Common Shareholders' Equity | 6.28 | 5.43 | 7.56 | 5.49 | 3.71 |
Minority Interest | 0.25 | 0 | - | - | - |
Shareholders' Equity | 6.52 | 5.44 | 7.56 | 5.49 | 3.71 |
Total Liabilities & Equity | 20.12 | 18.68 | 16.31 | 15.38 | 16.85 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 8.98 | 5.08 | 4.29 | 7.21 | 10.15 |
Net Cash (Debt) | -7.64 | -2.03 | -2.34 | -6 | -8.59 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.41 | -1.30 | -1.73 | -4.43 | -6.34 |
Book Value | 6.28 | 5.43 | 7.56 | 5.49 | 3.71 |
Book Value Per Share | 0.33 | 3.47 | 5.58 | 4.05 | 2.74 |
Tangible Book Value | 6.28 | 5.43 | 7.56 | 5.49 | 3.71 |
Tangible Book Value Per Share | 0.33 | 3.47 | 5.58 | 4.05 | 2.74 |